Brief: Rallybio Announces Initiation Of Phase 2 Clinical Trial Of RLYB212
21/11/2024 13:06
Nov 21 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO ANNOUNCES INITIATION OF PHASE 2 CLINICAL TRIAL OF
RLYB212
* RALLYBIO CORP - PHASE 2 TRIAL TO ASSESS PK AND SAFETY OF
RLYB212
* RALLYBIO CORP - TRIAL TO ENROLL PARTICIPANTS IN BELGIUM,
NETHERLANDS, NORWAY, SWEDEN, UK
Source text: ID:nBw8vrdhZa
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx